BioCentury
ARTICLE | Clinical News

Natesto regulatory update

April 14, 2017 4:32 PM UTC

Hyundai submitted an NDA to South Korea’s Ministry of Food and Drug Safety (MFDS) for Natesto to treat low testosterone. Hyundai has exclusive, South Korean rights to the bioadhesive intranasal gel fo...